肺癌患者就医延迟影响因素及干预措施研究进展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

江淀淀 ¹ ,  崔妙玲 ² , 李惠颜 ³ , 陈泉芳 ¹

1. ;
2. ;
3. ;

Corresponding author：

崔妙玲, Email: cuimiaoling@126.com

Keywords：

DOI：

10.7507/1671-6205.202302057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 江淀淀, 崔妙玲, 李惠颜, 陈泉芳. 肺癌患者就医延迟影响因素及干预措施研究进展. Chinese Journal of Respiratory and Critical Care Medicine, 2023, 22(6): 452-456. doi: 10.7507/1671-6205.202302057 Copy

1.	Shankar A, Saini D, Dubey A, et al. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res, 2019, 8(Suppl 1): S106-S121.
2.	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
3.	Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ, 2020, 4(371): m4087.
4.	缪爱云. 我国癌症病人就医延迟现状研究的文献分析. 循证护理, 2021, 7(3): 382-385.
5.	余柳莹. 350例肺癌患者首发症状与就诊延迟相关性分析. 中国医药科学, 2021, 11(2): 187 -190.
6.	Albano D, Bilfinger T, Feraca M, et al. A multidisciplinary lung cancer program: does it reduce delay between diagnosis and treatment? Lung, 2020, 198(6): 967-972.
7.	Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Thorac Oncol, 2016, 11(1): 39-51.
8.	Borges M, Gouveia M, Alarcão J, et al. Cost and burden of non-small cell lung cancer’s in Portugal. Value Health, 2014, 17(7): A626.
9.	林璜, William W. Au, 欧利民. 癌症延迟就医研究. 中国肿瘤, 2016, 25(9): 667-671.
10.	Koo MM, Zhou Y, Lyratzopoulos G. Delays in diagnosis and treatment of lung cancer: Lessons from US healthcare settings. Cancer Epidemiol, 2015, 39(11): 45-47.
11.	Vinas F, Ben Hassen I, Jabot L, et al. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J, 2016, 10(2): 67-71.
12.	González-Barcala FJ, García-Prim JM, Alvarez-Dobaño JM, et al. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol, 2010, 12(8): 36-42.
13.	Lubuzo B, Ginindza T, Hlongwana K. The barriers to initiating lung cancer care in low-and middle-income countries. Pan Afr Med J, 2020, 12: 35-38.
14.	邹浩, 姜东旭, 张琳琳. 慢性病患者就医延迟评估工具及影响因素的研究进展. 中国全科医学, 2022, 25(7): 893-898.
15.	Li PW, Lee DT, Yu DS. Psychometric evaluation of the perceived barriers to health care-seeking decision in Chinese patients with acute coronary syndromes. Heart Lung, 2014, 43(2): 140-145.
16.	杨柳青, 郝志红. Fischer就医态度量表的汉化及信效度分析. 中华行为医学与脑科学杂志, 2020, 29(8): 757-762.
17.	王蕊琪, 贾红红, 周郁秋. 糖尿病诊治延误认知行为意向量表的开发与验证. 中国全科医学, 2021, 24(18): 2342-2348, 2358.
18.	赵秋利, 吴燕妮. 缺血性卒中高危者院前延迟行为意向测评量表的编制与验证. 中国全科医学, 2012, 15(32): 3703-3706, 3709.
19.	Lubuzo B, Ginindza T, Hlongwana K. Exploring barriers to lung cancer patient access, diagnosis, referral and treatment in Kwazulu-Natal, South Africa: the health providers' perspectives. Transl Lung Cancer Res, 2019, 8(4): 380-391.
20.	Mapanga W, Norris SA, Chen WC, et al. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One, 2021, 16(2): e0246716.
21.	Malalasekera A, Dhillon HM, Shunmugasundaram C, et al. Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians. Asia Pac J Clin Oncol, 2021, 17(2): e77-e86.
22.	van Os S, Syversen A, Whitaker KL, et al. Lung cancer symptom appraisal, help-seeking and diagnosis-rapid systematic review of differences between patients with and without a smoking history. Psychooncology, 2022, 31(4): 562-576.
23.	陈庆馀. 台湾家庭医学的发展与挑战. 中国全科医学, 2016, 19(4): 375-377.
24.	Amadori D, Serra P, Bucchi L, et al. The mwanza cancer project. Lancet Oncol, 2016, 17(2): 146-148.
25.	Barata F, Fidalgo P, Figueiredo S, et al. Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. PLoS One, 2021, 16(6): e0252529.
26.	周敏, 许震娟. 慢阻肺急性加重期患者延迟就医与家庭动力学的相关性研究. 临床肺科杂志, 2022, 27(2): 222-225, 236.
27.	董建新, 杨华, 徐小琴, 等. 医疗卫生服务可及性的分析框架: 复杂性视角. 医学与哲学, 2022, 43(16): 7-11.
28.	陈兰馨, 李跃平. 医疗服务可及性对居民健康状况的影响研究—基于CFPS数据的实证分析. 南京医科大学学报(社会科学版), 2022, 22(3): 278-284.
29.	Aukst Margetic B, Kukulj S, Galic K, et al. Personality and stigma in lung cancer patients. Psychiatr Danub, 2020, 32(Suppl 4): 528-532.
30.	Marlow LAV, Waller J, Wardle J. Does lung cancer attract greater stigma than other cancer types? Lung Cancer, 2015, 88: 104–107.
31.	杨晶莹, 刘科群, 章丽贞. 健康素养和社会支持对中青年首发脑卒中患者就医延迟意向的影响分析. 实用预防医学, 2023, 30(5): 607-610.
32.	叶慧. 追踪护理模式在改善肿瘤患者就医决策延迟中的应用研究. 甘肃科技, 2023, 39(2): 90-94.
33.	Cancino RS, Su Z, Mesa R, et al. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer, 2020, 6(2): e21697.
34.	Sha Z, Chang K, Mi J, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med, 2020, 9(5): 3373-3378.
35.	王子予, 韩茜宇, 郝艳华, 等. 新冠肺炎疫情下慢性病患者就医延迟问题调查与分析. 中国医院管理, 2022, 42(3): 43-47.
36.	Singh AP, Berman AT, Marmarelis ME, et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract, 2020, 16(9): 579-586.
37.	赫捷, 李霓, 陈万青, 等. 中国肺癌筛查与早诊早治指南(2021, 北京). 中华肿瘤杂志, 2021, 43(3): 243-268.
38.	Peter J, Gerard A, Lesley H, et al. Screening for lung cancer CHEST guideline and expert panel report. Chest, 2021, 160(5): e427-e494.
39.	Haaf KT, Bastani M, Cao P, et al. A comparative modeling analysis of risk-based lung cancer screening strategies. J Natl Cancer Inst, 2020, 112(5): 466-479.
40.	王芬, 张绮珊, 孙兴兰, 等. 信息框架对居民脑卒中就医延迟行为意向的影响研究. 中国全科医学, 2023, 26(1): 64-73.
41.	Zhang J, IJzerman MJ, Oberoi J, et al. Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer, 2022, 166: 27-39.
42.	中国县域医院肺癌筛查共识编写专家组, 中华医学会呼吸分会肺癌学组. 中国县域肺癌筛查共识(2020年). 中华医学杂志, 2021, 101(14): 979-988.
43.	Maklouf-Quirós A, Simithy J, Ragoobar K, et al. Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals' perspectives. Support Care Cancer, 2021, 29(2): 751-757.
44.	Somayaji D, Mohedat H, Dean GE, et al. Patients' perceptions at diagnosis: lung cancer discovery and provider relationships. Cancer Nurs, 2022, 45(5): 397-405.
45.	Saab MM, McCarthy M, O'Driscoll M, et al. A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms. NPJ Prim Care Respir Med, 2022, 32(1): 42.
46.	Patel S, Issaka RB, Chen E, et al. Colorectal cancer screening and COVID-19. Am J Gastroenterol, 2021, 116(2): 433-434.
47.	Varela-Centelles P, Seoane J, Bilbao A, et al. Covid-19 pandemic: a new contributing factor to diagnostic and treatment delay in oral cancer patients. Oral Oncol, 2021, 116: 105176.

1. Shankar A, Saini D, Dubey A, et al. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res, 2019, 8(Suppl 1): S106-S121.
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
3. Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ, 2020, 4(371): m4087.
4. 缪爱云. 我国癌症病人就医延迟现状研究的文献分析. 循证护理, 2021, 7(3): 382-385.
5. 余柳莹. 350例肺癌患者首发症状与就诊延迟相关性分析. 中国医药科学, 2021, 11(2): 187 -190.
6. Albano D, Bilfinger T, Feraca M, et al. A multidisciplinary lung cancer program: does it reduce delay between diagnosis and treatment? Lung, 2020, 198(6): 967-972.
7. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Thorac Oncol, 2016, 11(1): 39-51.
8. Borges M, Gouveia M, Alarcão J, et al. Cost and burden of non-small cell lung cancer’s in Portugal. Value Health, 2014, 17(7): A626.
9. 林璜, William W. Au, 欧利民. 癌症延迟就医研究. 中国肿瘤, 2016, 25(9): 667-671.
10. Koo MM, Zhou Y, Lyratzopoulos G. Delays in diagnosis and treatment of lung cancer: Lessons from US healthcare settings. Cancer Epidemiol, 2015, 39(11): 45-47.
11. Vinas F, Ben Hassen I, Jabot L, et al. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J, 2016, 10(2): 67-71.
12. González-Barcala FJ, García-Prim JM, Alvarez-Dobaño JM, et al. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol, 2010, 12(8): 36-42.
13. Lubuzo B, Ginindza T, Hlongwana K. The barriers to initiating lung cancer care in low-and middle-income countries. Pan Afr Med J, 2020, 12: 35-38.
14. 邹浩, 姜东旭, 张琳琳. 慢性病患者就医延迟评估工具及影响因素的研究进展. 中国全科医学, 2022, 25(7): 893-898.
15. Li PW, Lee DT, Yu DS. Psychometric evaluation of the perceived barriers to health care-seeking decision in Chinese patients with acute coronary syndromes. Heart Lung, 2014, 43(2): 140-145.
16. 杨柳青, 郝志红. Fischer就医态度量表的汉化及信效度分析. 中华行为医学与脑科学杂志, 2020, 29(8): 757-762.
17. 王蕊琪, 贾红红, 周郁秋. 糖尿病诊治延误认知行为意向量表的开发与验证. 中国全科医学, 2021, 24(18): 2342-2348, 2358.
18. 赵秋利, 吴燕妮. 缺血性卒中高危者院前延迟行为意向测评量表的编制与验证. 中国全科医学, 2012, 15(32): 3703-3706, 3709.
19. Lubuzo B, Ginindza T, Hlongwana K. Exploring barriers to lung cancer patient access, diagnosis, referral and treatment in Kwazulu-Natal, South Africa: the health providers' perspectives. Transl Lung Cancer Res, 2019, 8(4): 380-391.
20. Mapanga W, Norris SA, Chen WC, et al. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One, 2021, 16(2): e0246716.
21. Malalasekera A, Dhillon HM, Shunmugasundaram C, et al. Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians. Asia Pac J Clin Oncol, 2021, 17(2): e77-e86.
22. van Os S, Syversen A, Whitaker KL, et al. Lung cancer symptom appraisal, help-seeking and diagnosis-rapid systematic review of differences between patients with and without a smoking history. Psychooncology, 2022, 31(4): 562-576.
23. 陈庆馀. 台湾家庭医学的发展与挑战. 中国全科医学, 2016, 19(4): 375-377.
24. Amadori D, Serra P, Bucchi L, et al. The mwanza cancer project. Lancet Oncol, 2016, 17(2): 146-148.
25. Barata F, Fidalgo P, Figueiredo S, et al. Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. PLoS One, 2021, 16(6): e0252529.
26. 周敏, 许震娟. 慢阻肺急性加重期患者延迟就医与家庭动力学的相关性研究. 临床肺科杂志, 2022, 27(2): 222-225, 236.
27. 董建新, 杨华, 徐小琴, 等. 医疗卫生服务可及性的分析框架: 复杂性视角. 医学与哲学, 2022, 43(16): 7-11.
28. 陈兰馨, 李跃平. 医疗服务可及性对居民健康状况的影响研究—基于CFPS数据的实证分析. 南京医科大学学报(社会科学版), 2022, 22(3): 278-284.
29. Aukst Margetic B, Kukulj S, Galic K, et al. Personality and stigma in lung cancer patients. Psychiatr Danub, 2020, 32(Suppl 4): 528-532.
30. Marlow LAV, Waller J, Wardle J. Does lung cancer attract greater stigma than other cancer types? Lung Cancer, 2015, 88: 104–107.
31. 杨晶莹, 刘科群, 章丽贞. 健康素养和社会支持对中青年首发脑卒中患者就医延迟意向的影响分析. 实用预防医学, 2023, 30(5): 607-610.
32. 叶慧. 追踪护理模式在改善肿瘤患者就医决策延迟中的应用研究. 甘肃科技, 2023, 39(2): 90-94.
33. Cancino RS, Su Z, Mesa R, et al. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer, 2020, 6(2): e21697.
34. Sha Z, Chang K, Mi J, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med, 2020, 9(5): 3373-3378.
35. 王子予, 韩茜宇, 郝艳华, 等. 新冠肺炎疫情下慢性病患者就医延迟问题调查与分析. 中国医院管理, 2022, 42(3): 43-47.
36. Singh AP, Berman AT, Marmarelis ME, et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract, 2020, 16(9): 579-586.
37. 赫捷, 李霓, 陈万青, 等. 中国肺癌筛查与早诊早治指南(2021, 北京). 中华肿瘤杂志, 2021, 43(3): 243-268.
38. Peter J, Gerard A, Lesley H, et al. Screening for lung cancer CHEST guideline and expert panel report. Chest, 2021, 160(5): e427-e494.
39. Haaf KT, Bastani M, Cao P, et al. A comparative modeling analysis of risk-based lung cancer screening strategies. J Natl Cancer Inst, 2020, 112(5): 466-479.
40. 王芬, 张绮珊, 孙兴兰, 等. 信息框架对居民脑卒中就医延迟行为意向的影响研究. 中国全科医学, 2023, 26(1): 64-73.
41. Zhang J, IJzerman MJ, Oberoi J, et al. Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer, 2022, 166: 27-39.
42. 中国县域医院肺癌筛查共识编写专家组, 中华医学会呼吸分会肺癌学组. 中国县域肺癌筛查共识(2020年). 中华医学杂志, 2021, 101(14): 979-988.
43. Maklouf-Quirós A, Simithy J, Ragoobar K, et al. Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals' perspectives. Support Care Cancer, 2021, 29(2): 751-757.
44. Somayaji D, Mohedat H, Dean GE, et al. Patients' perceptions at diagnosis: lung cancer discovery and provider relationships. Cancer Nurs, 2022, 45(5): 397-405.
45. Saab MM, McCarthy M, O'Driscoll M, et al. A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms. NPJ Prim Care Respir Med, 2022, 32(1): 42.
46. Patel S, Issaka RB, Chen E, et al. Colorectal cancer screening and COVID-19. Am J Gastroenterol, 2021, 116(2): 433-434.
47. Varela-Centelles P, Seoane J, Bilbao A, et al. Covid-19 pandemic: a new contributing factor to diagnostic and treatment delay in oral cancer patients. Oral Oncol, 2021, 116: 105176.

Previous Article
骨膜蛋白在特发性肺纤维化中的研究进展

Chinese Journal of Respiratory and Critical Care Medicine

肺癌患者就医延迟影响因素及干预措施研究进展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content